AstraZeneca Guards Nexium Patent, Takes Teva, Cipla To New Jersey Court
This article was originally published in PharmAsia News
Executive Summary
MUMBAI - AstraZeneca, the maker of world's second largest selling drug brand Nexium (esomperazole) is going all out to protect the patent covering its popular anti-ulcer medicine